
PDI,
Inc. Announces Resignation of Steven K. Budd
as
President, Sales Services
SADDLE
RIVER, N.J. - (April 2, 2007) - PDI, Inc. (NASDAQ:PDII),
a
provider of commercialization services to the biopharmaceutical industry, today
announced that Steven K. Budd has resigned his position as president of the
sales services segment, effective April 6, 2007. Mr. Budd has been with PDI
since 1996. PDI is initiating a process to identify Mr. Budd’s successor and
until a successor has been named, senior management of this unit will report
directly to Michael Marquard, PDI’s chief executive officer.
"We
appreciate Steve’s long, dedicated service to PDI, and his focus on our
stockholders, customers and employees. We wish Steve the very best in the
future,” Mr. Marquard stated.
Mr.
Budd
commented, “I would like to thank PDI, the board of directors, stockholders,
customers and my colleagues for the confidence and trust you placed in me.
I
have truly enjoyed being a part of such a great company, and as I move forward
with the next chapter in my career, I remain an ardent supporter of PDI, its
excellent people and the outstanding service they provide.”
About
PDI
PDI
provides commercialization services for established and emerging
biopharmaceutical companies. The Company is dedicated to maximizing the return
on investment for its customers by providing strategic flexibility; sales,
marketing and commercialization expertise. PDI operates in two areas, sales
services and marketing services. Our sales services include our Performance
Sales Teams™, which are dedicated teams for specific clients; and Select
Access™, our targeted sales solution that leverages an existing infrastructure.
Our marketing services include marketing research and consulting services
through TVG in Dresher, PA, and medical communications services through
Pharmakon in Schaumburg, IL. In addition, PDI is a high-quality provider of
ACCME-accredited continuing medical education through Vital Issues in Medicine
(VIM®), located in Dresher, PA. PDI's experience extends across multiple
therapeutic categories and includes office and hospital based
initiatives.
PDI's
commitment is to deliver innovative solutions, unparalleled execution and
superior results for its customers. Recognized as an industry pioneer, PDI
remains committed to continuous innovation and to retaining the industry's
highest-quality employees. For more information, please visit the Company's
website at www.pdi-inc.com.
CONTACT:
PDI, Inc.
Jeff
Smith, Chief Financial Officer, 201-258-8451
JESmith@pdi-inc.com
www.pdi-inc.com
or
Investor
Contacts:
Lippert/Heilshorn
& Associates, Inc.
Kim
Sutton Golodetz, 212-838-3777
kgolodetz@lhai.com
Bruce
Voss, 310-691-7100
bvoss@lhai.com